Waters Releases Q1 2026 Financial Results

AlphaStreet Newsdesk powered by AlphaStreet Intelligence

WAT|Adj. EPS $2.70 vs $2.36 est (+16.9%)|Rev $1.27B

Waters Corporation (WAT) crushed first-quarter expectations, posting adjusted earnings of $2.70 per share that sailed past the $2.36 analyst consensus by 16.9%. The analytical workflow solutions provider reported revenue of $1.27B, representing a dramatic 91.0% surge from the $662.0M recorded in the year-ago quarter. Organic revenue growth clocked in at 13.0% for the period.

The Analytical Sciences Division powered the quarter’s performance, generating $607.0M in revenue with a 14.0% year-over-year increase. Waters serves customers across Asia, the Americas, and Europe with its portfolio of laboratory instruments and consumables used in pharmaceutical development, clinical diagnostics, and applied research applications. The company maintained a workforce of 16,000 total employees at quarter end.

Management issued full-year guidance targeting adjusted earnings between $14.40 and $14.60 per share on revenue of $6.41B to $6.46B for fiscal 2026. The robust quarterly results and forward outlook come as demand for analytical instruments remains strong across Waters’ key end markets, particularly in biopharmaceutical research and quality control applications.

Wall Street maintains a mixed stance on the stock with 9 buy ratings and 12 hold ratings, with no analysts recommending selling shares.

A detailed analysis of Waters Corporation’s quarter follows shortly on AlphaStreet.

This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.